FDA Patient-Focused Drug Development Guidances
2023 · Neurology · 30 citations
https://doi.org/10.1212/wnl.0000000000207958
C
Chere Chapman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
16
Papers
202
Citations
8
h-index
8
i10-index
Chere Chapman is an academic researcher from Health Outcomes Solutions (United States). The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Genomics and Rare Diseases & Genetics and Neurodevelopmental Disorders. The author has an h-index of 8, co-authored 14 publications.
ORCID: 0000-0003-2577-390XPapers by this author
worksA systematic review of goal attainment scaling implementation practices by caregivers in randomized controlled trials
2024 · Journal of Patient-Reported Outcomes · 4 citations
https://doi.org/10.1186/s41687-024-00716-w
The Feasibility of Personalized Endpoints in Assessing Treatment Outcomes for Rare Diseases: A Pilot Study of Goal Attainment Scaling in SCN2A-Associated Developmental Epileptic Encephalopathy
2024 · Value in Health · 2 citations
https://doi.org/10.1016/j.jval.2024.12.004
CO12 A Review of Goal Attainment Scaling Implementation As a Personalized Clinical Outcome Assessment over the Last Decade
2024 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2024.03.101
PCR82 Evaluating the Feasibility and Acceptability of a Personalized Endpoint: A Prospective Mixed Methods Study of Inventory-Facilitated Goal Attainment Scaling
2025 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2025.09.2555
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat